SANG SANG
Company Profile ↓Company Overview
SANG (SANG) is a publicly traded company listed on with a market capitalization of $132.72M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.22.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Jun 2025 Revenue of $236.69M (-4.3% YoY); net profit $-5.01M.
- Trailing 12 Months Year-on-year growth — revenue -4.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 1.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 1.80% |
| 1 Year: | -4.28% |
Stock Price Performance
| 1 Year: | -28.62% |
| 6 Months: | -18.57% |
| 3 Months: | -3.86% |
| 1 Month: | -0.50% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)49.92 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- Trading 34.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 58.07M | 59.36M | 50.82M | 51.45M | 50.99M |
| Cost of Revenue | - | 18.03M | 19.32M | 14.01M | 13.20M | 14.63M |
| Gross Profit | - | 40.04M | 40.04M | 36.80M | 38.25M | 36.36M |
| Operating Expenses | - | 40.60M | 39.06M | 38.46M | 39.96M | 38.48M |
| Operating Income | - | -566.00K | 978.00K | -1.65M | -1.72M | -2.12M |
| EBITDA | - | 10.62M | 11.47M | 8.88M | 9.04M | 8.29M |
| Interest Expense | - | 943.00K | 807.00K | 790.00K | 582.00K | 535.00K |
| Pretax Income | - | -1.71M | -226.00K | -2.86M | -2.33M | -2.92M |
| Tax Provision | - | -281.00K | -435.00K | -526.00K | -336.00K | -586.00K |
| Net Income | - | -1.43M | 209.00K | -2.34M | -2.00M | -2.33M |
| Diluted EPS | -0.06 | -0.04 | - | -0.07 | -0.06 | -0.07 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 224.35M | 252.53M | 247.28M | 236.69M |
| Cost of Revenue | 67.46M | 79.74M | 74.46M | 74.94M |
| Gross Profit | 156.89M | 172.79M | 172.82M | 161.75M |
| Operating Expenses | 162.41M | 175.74M | 173.88M | 163.02M |
| Operating Income | -5.53M | -2.95M | -1.06M | -1.27M |
| EBITDA | -61.16M | 19.95M | 42.32M | 42.95M |
| Interest Expense | 3.88M | 6.77M | 6.66M | 4.25M |
| Pretax Income | -104.39M | -31.96M | -9.50M | -6.34M |
| Tax Provision | 6.39M | -2.93M | -840.00K | -1.33M |
| Net Income | -110.78M | -29.03M | -8.66M | -5.01M |
| Diluted EPS | -3.52 | -0.88 | -0.26 | -0.15 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Total Assets | 498.53M | 443.02M | 400.64M | 346.55M |
| Current Assets | 60.31M | 61.90M | 57.11M | 42.62M |
| Cash & Equivalents | 12.70M | 11.16M | 16.23M | 13.49M |
| Inventory | 17.43M | 17.97M | 14.77M | 8.23M |
| Receivables | 16.05M | 16.06M | 16.02M | 10.63M |
| Total Liabilities | 204.72M | 176.90M | 140.91M | 92.35M |
| Current Liabilities | 78.41M | 63.46M | 60.10M | 49.48M |
| Long Term Debt | 86.92M | 83.12M | 57.95M | 27.30M |
| Total Debt | 122.61M | 115.16M | 89.11M | 56.11M |
| Total Equity | 293.81M | 266.12M | 259.73M | 254.19M |
| Shares Outstanding | 21.44M | 33.04M | 33.34M | 33.26M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 21.06M | 26.49M | 44.25M | 41.79M |
| Investing Cash Flow | -55.82M | -11.27M | -10.91M | -8.84M |
| Financing Cash Flow | 25.37M | -16.77M | -28.26M | -35.68M |
| Capital Expenditure | -5.11M | -11.27M | -10.91M | -8.84M |
| Free Cash Flow | 15.95M | 15.22M | 33.33M | 32.95M |
| Net Change in Cash | -9.39M | -1.55M | 5.08M | -2.74M |
Ratios (Annual)
Figures in %.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Gross Margin % | 69.9% | 68.4% | 69.9% | 68.3% |
| Operating Margin % | -2.5% | -1.2% | -0.4% | -0.5% |
| Net Margin % | -49.4% | -11.5% | -3.5% | -2.1% |
| ROE % | -37.7% | -10.9% | -3.3% | -2.0% |
| ROCE % | -1.3% | -0.8% | -0.3% | -0.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SANG
Sangoma Technologies Corporation (SANG) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQSHZGcldfMlZkeUg0dzM5QzZZWklNQjZ2RkFJaXpqNy1PZ0tSN1poNFBWWjI0cjJNZXRYbVBLck8wcFI2R0dyNFR3akJJVFZwbmRFUjh4RjVrcUZNbDl2MjFtaHVJV2JDZzBpZ3J3ajhsd2xJaFFxb0o0WXBDTlFGTE0tZWZOSUZMdnM1bU…
Sang Hing Sets September AGM to Approve Accounts, Board Mandates and Share Issuance Authority - theglobeandmail.com
<a href="https://news.google.com/rss/articles/CBMigwJBVV95cUxPNEp6aE9Kd1NlMlpQc3RBX240MTJoa3JXX1hnRjBmdm9SRVB3RkZlNm5pdmxsQUNjdV9lb0hZQ1h3QllDMDVjOFRIX3hoVGVLQW1pWV9fVC15aThXeFIwVl9DcEJ2RUJ2cE5RUWU4Z2F2dVo3bDEwTmZmXzU2dkhQdnFxVUFzdTZzcDFYZT…
SANG|Sangoma Technologies Corp|Price:3.830|Chg%:-0.155 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1RUEZ3QTB2cXFYcXozMVl1X1hJTGdFR2pIR3VQS3dYZVZTV3ZNTGdHOTVzcGxxa3FkdWZZdF80bFZDbURiSjZ4WUl6eGFPbnAtR0pLMlF4QWpzZ3FQQU5JcUFDSWZqaVRhOXJfU0NB?oc=5" target="_blank">SANG|Sangoma Techno…
Zimmer Biomet group president Yi Sang sells $413,216 in stock - Investing.com
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSF9CYXVDdEhUVFFJVU80Q3J0NnJvZUR0WlJmQm9ScFRVU3FETUo3QVdIN0w3MGNtb05fYnRwMFlTcTRkekdUVHhSb0trajFRN2E5cHBCYkF1VEdSV0l3WkpYa2MxbXdrRnhlTzN1SWlTTDgzQ2xIZ2VCamJ2VW9POHRWcXdkMkRfNTNZdn…
MBC Announcer Regrets Early SK Hynix Stock Sale - 조선일보
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOc0JPMGx0dWlheUlPWlI0dWtsQjJZTXk1VU1hQ0pTdGZfTGVITFFjWEpHZ0FnZjRpUmpEd2ZwTHpSbkZEVjJJU0tTbld0SWg1Y2hYQ0l4d2dHRVc0aGQ2YVVaVFc4RnFsUHpxRHE5bm9pazFURG45dFVvWTZFOXBFS2I1ZDNwRENJeEZUcE…
Sangoma Announces Date of Third Quarter Fiscal 2026 Financial Results and Conference Call - Business Wire
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxQcy13M3Zzd09XdmxzSXgyMHJSTmN0REhKaVlKb3JXV2FFZjE5YzlaVExrMGtDVnhzcEI5ZjhxOFBsOWwzTHBZTjVxYXh1S0NFbUtzWGF5VkFvbUg0b2dQQU14N1gwNVpkQkdMS1FYVW9jejh4UDlGdGtwdmEtU3ZwTHhaaXJmblVmSWhPS2…
SANG — Frequently Asked Questions
What is the current share price of SANG?
As of 2026-08-05 17:25 PDT, SANG trades at $3.99 on NASDAQ/NYSE. Its 52-week range is $3.46 to $6.08.
What is the market capitalisation of SANG?
SANG has a market capitalisation of $132.72M on NASDAQ/NYSE.
What is the P/E ratio of SANG?
SANG trades at a trailing price-to-earnings (P/E) ratio of -26.60. Its price-to-book (P/B) ratio is 0.52.
What is the return on equity (ROE) of SANG?
SANG has a return on equity (ROE) of -1.97%. Its return on capital employed (ROCE) is -0.43%.
Is SANG a good stock to buy?
This page provides a data-driven analysis of SANG, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.